Parallax Volatility Advisers’s NovoCure NVCR Stock Holding History

Parallax Volatility Advisers’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-10,183	Closed	-$159K	–	2201
2024 Q1	$159K	Buy	10,183 +8,315	+445%	+$122K	﹤0.01%	1573
2023 Q4	$27.9K	Buy	+1,868	New	+$25K	﹤0.01%	1966
2023 Q3	–	Sell	-9,818	Closed	-$407K	–	2505
2023 Q2	$407K	Buy	+9,818	New	+$610K	﹤0.01%	1706
2021 Q2	–	Sell	-9,187	Closed	-$1.79M	–	1562
2021 Q1	$1.21M	Buy	9,187 +4,289	+88%	+$678K	﹤0.01%	791
2020 Q4	$848K	Sell	4,898 -8,053	-62%	-$1.1M	﹤0.01%	1496
2020 Q3	$1.44M	Sell	12,951 -17,853	-58%	-$1.43M	﹤0.01%	1835
2020 Q2	$1.83M	Sell	30,804 -23,971	-44%	-$1.58M	﹤0.01%	1496
2020 Q1	$3.69M	Buy	+54,775	New	+$4.33M	﹤0.01%	993
2019 Q1	–	Sell	-3,089	Closed	-$103K	–	3617
2018 Q4	$103K	Buy	+3,089	New	+$113K	﹤0.01%	1933
2018 Q3	–	Sell	-19,020	Closed	-$595K	–	3258
2018 Q2	$595K	Buy	+19,020	New	+$529K	﹤0.01%	1225
2018 Q1	–	Sell	-8,778	Closed	-$189K	–	3598
2017 Q4	$177K	Buy	+8,778	New	+$169K	﹤0.01%	2374

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Parallax Volatility Advisers's NVCR Position: Q2 2024 in Review

Parallax Volatility Advisers sold out of NovoCure (NVCR) in Q2 2024, closing a stake of 10,183 shares — an estimated $159K sold.

Parallax Volatility Advisers first reported a position in NVCR in Q4 2017 and held it in 11 quarters. The position peaked at $3.69M in Q1 2020. 236 funds tracked by Wall St. Rank hold NVCR as of Q2 2024.

Parallax Volatility Advisers reported no remaining NovoCure position as of Q2 2024 after selling out during the quarter.
Parallax Volatility Advisers sold 10,183 NovoCure shares in Q2 2024, an estimated $159K.
Parallax Volatility Advisers first reported a position in NovoCure in Q4 2017 and held it in 11 quarters.
Parallax Volatility Advisers's NovoCure position peaked at $3.69M in Q1 2020.
236 funds tracked by Wall St. Rank held NovoCure as of Q2 2024.

Based on Parallax Volatility Advisers's 13F filing for Q2 2024, filed 14 Aug 2024.